Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook
admin Illumina Inc. shares sank more than 22% after hours Thursday after the gene-sequencing company swung…
Read MoreHealthcare/Life Sciences
Opinion: Scary ads claiming Medicare is being stripped by $300 billion are playing you
If you’re among the hundreds of thousands—possibly more—who have seen one of these commercials about…
Read MoreOpinion: Sensible stock investors put their money on a company’s real profits — not Wall Street’s false prophets
How many times have you heard, “If you had invested in Microsoft at the beginning…”…
Read MoreCalifornia man charged with naming phony film studio Desilu after famed ‘I Love Lucy’ production company to swindle investors
It was nothing to sneeze at. A man who co-created the cold remedy, Zicam, has…
Read MoreTrulieve trims view as inflation hits cannabis prospects
Trulieve Cannabis Corp. on Wednesday swung to a loss and cut its revenue outlook for…
Read MoreGet ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read MoreOpinion: Why the Inflation Reduction Act is a very big deal for Americans
NEW YORK—Senate Democrats’ compromise bill, the Inflation Reduction Act (IRA) of 2022, addresses not just…
Read MoreNovavax slashes sales guidance in half, stock plunges 34%
Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial…
Read MoreNovavax slashes sales guidance in half, stock plunges 30%
Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial…
Read More
Opinion: The FDA should ban imports of unsafe generic drugs now
More than 131 million Americans take prescription drugs each day. And almost all of these…
Read More